Genetic bases and phenotypes of autosomal recessive Parkinson disease in a Turkish population

European Journal of Neurology

Volumn 19, Issue 5, 2012, Pages 769-775

  Lohmann, E ^a   Dursun, B ^b   Lesage, S ^c,d,e   Hanagasi, H A ^a   Sevinc, G ^b   Honore, A ^c,d,e   Bilgic, B ^a   Gurvit H ^a   Dogu, O ^f   Kaleagasi, H ^f   Babacan, G ^a   Yazici, J ^a   Erginel Unaltuna, N ^b   Brice, A ^c,d,e,g   Emre, M ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

^b ISTANBUL UNIVERSITY   (Turkey)

^c SORBONNE UNIVERSITÉ   (France)

^d INSERM   (France)

^e CNRS   (France)

^f MERSIN UNIVERSITY   (Turkey)

^g ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

Autosomal recessive PD; Consanguinity; Early onset PD; Mutation; Parkin gene; Parkinson disease (PD); PINK1; Turkey

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; EXON; FEMALE; GENE REARRANGEMENT; GENE SEQUENCE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PARKINSON DISEASE; PHENOTYPE; POINT MUTATION; PRIORITY JOURNAL; SEQUENCE ANALYSIS; TURKEY (REPUBLIC);

ADOLESCENT; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CHILD; CHILD, PRESCHOOL; DNA MUTATIONAL ANALYSIS; FAMILY HEALTH; FEMALE; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MIDDLE AGED; MUTATION; ONCOGENE PROTEINS; PARKINSONIAN DISORDERS; PHENOTYPE; PROTEIN KINASES; SEX FACTORS; TURKEY; UBIQUITIN-PROTEIN LIGASES; YOUNG ADULT;

EID: 84859827343     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2011.03639.x     Document Type: Article

References (22)

1. Lesage S, Brice A. Parkinson's disease: from monogenic forms to genetic susceptibility factors. Hum Mol Genet 2009; 18: R48-R59.
2. Hattori N, Matsumine H, Asakawa S, et al. Point mutations (Thr240Arg and Gln311Stop) [correction of Thr240Arg and Ala311Stop] in the Parkin gene. Biochem Biophys Res Commun 1998; 249: 754-758.
3. Serdaroglu P, Hanagasi H, Tasli H, Emre M. Parkin expression in muscle from three patients with autosomal recessive Parkinson's disease carrying parkin mutation. Acta Myol 2005; 24: 2-5.
4. Apaydin H, Özekmekçi S, Uludüz D, Hatano Y, Mizuno Y, Hattori N. Homozygous PARK7 mutation in Parkinson's disease: case report of two brothers. Türk Nörol Derg 2008; 14: 172-178.
5. Tomiyama H, Li Y, Yoshino H, et al. Mutation analysis for DJ-1 in sporadic and familial parkinsonism: screening strategy in parkinsonism. Neurosci Lett 2009; 455: 159-161.
6. Tomiyama H, Li Y, Funayama M, et al. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries. Mov Disord 2006; 21: 1102-1108.
7. Pirkevi C, Lesage S, Condroyer C, et al. A LRRK2 G2019S mutation carrier from Turkey shares the Japanese haplotype. Neurogenetics 2009; 10: 271-273.
8. Hanagasi HA, Lohmann E, Dursun B, et al. LRRK2 mutation are uncommon in Turkey. Eur J Neurol 2011; 18: 137.
9. Kumazawa R, Tomiyama H, Li Y, et al. Mutation analysis of the PINK1 gene in 391 patients with Parkinson disease. Arch Neurol 2008; 65: 802-808.
10. Koc I. Prevalence and sociodemographic correlates of consanguineous marriages in Turkey. J Biosoc Sci 2008; 40: 137-148.
11. Lohmann E, Periquet M, Bonifati V, et al. How much phenotypic variation can be attributed to parkin genotype? Ann Neurol 2003; 54: 176-185.
12. Yamamura Y, Sobue I, Ando K, Iida M, Yanagi T. Paralysis agitans of early onset with marked diurnal fluctuation of symptoms. Neurology 1973; 23: 239-244.
13. Periquet M, Latouche M, Lohmann E, et al. Parkin mutations are frequent in patients with isolated early-onset parkinsonism. Brain 2003; 126(Pt 6): 1271-1278.
14. Nuytemans K, Theuns J, Cruts M, Van Broeckhoven C. Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update. Hum Mutat 2010; 31: 763-780.
15. Mitsui J, Takahashi Y, Goto J, et al. Mechanisms of genomic instabilities underlying two common fragile-site-associated loci, PARK2 and DMD, in germ cell and cancer cell lines. Am J Hum Genet 2010; 87: 75-89.
16. Periquet M, Lücking C, Vaughan J, et al. Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects. Am J Hum Genet 2001; 68: 617-626.
17. Romito LM, Contarino MF, Ghezzi D, Franzini A, Garavaglia B, Albanese A. High frequency stimulation of the subthalamic nucleus is efficacious in Parkin disease. J Neurol 2005; 252: 208-211.
18. Brooks J, Ding J, Simon-Sanchez J, Paisan-Ruiz C, Singleton AB, Scholz SW. Parkin and PINK1 mutations in early-onset Parkinson's disease: comprehensive screening in publicly available cases and control. J Med Genet 2009; 46: 375-381.
19. Staropoli JF, McDermott C, Martinat C, Schulman B, Demireva E, Abeliovich A. Parkin is a component of an SCF-like ubiquitin ligase complex and protects postmitotic neuronsfrom kainate excitotoxicity. Neuron 2003; 37: 735-749.
20. Klein C, Pramstaller PP, Kis B, et al. Parkin deletions in a family with adult-onset, tremor-dominant parkinsonism: expanding the phenotype. Ann Neurol 2000; 48: 65-71.
21. Sun M, Latourelle JC, Wooten GF, et al. Influence of heterozygosity for parkin mutation on onset age in familial Parkinson disease: the GenePD study. Arch Neurol 2006; 63: 826-832.
22. Lesage S, Lohmann E, Tison F, Durif F, Dürr A, Brice A. Rare heterozygous parkin variants in French early-onset Parkinson disease patients and controls. J Med Genet 2008; 45: 43-46.